SK111195A3 - Bicyclic ethers substituted with oxazole and thiazole, process for producing thereof and pharmaceutical composition containing same - Google Patents
Bicyclic ethers substituted with oxazole and thiazole, process for producing thereof and pharmaceutical composition containing same Download PDFInfo
- Publication number
- SK111195A3 SK111195A3 SK1111-95A SK111195A SK111195A3 SK 111195 A3 SK111195 A3 SK 111195A3 SK 111195 A SK111195 A SK 111195A SK 111195 A3 SK111195 A3 SK 111195A3
- Authority
- SK
- Slovakia
- Prior art keywords
- formula
- group
- compound
- hydrogen atom
- salt
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30524994A | 1994-09-13 | 1994-09-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK111195A3 true SK111195A3 (en) | 1997-06-04 |
Family
ID=23180015
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1111-95A SK111195A3 (en) | 1994-09-13 | 1995-09-06 | Bicyclic ethers substituted with oxazole and thiazole, process for producing thereof and pharmaceutical composition containing same |
Country Status (26)
| Country | Link |
|---|---|
| EP (1) | EP0702015B1 (fr) |
| JP (1) | JPH08109183A (fr) |
| KR (1) | KR960010649A (fr) |
| CN (1) | CN1130186A (fr) |
| AT (1) | ATE158585T1 (fr) |
| AU (1) | AU3055295A (fr) |
| BR (1) | BR9504004A (fr) |
| CA (1) | CA2157950A1 (fr) |
| CO (1) | CO4410332A1 (fr) |
| CZ (1) | CZ229595A3 (fr) |
| DE (1) | DE69500758T2 (fr) |
| DK (1) | DK0702015T3 (fr) |
| ES (1) | ES2108550T3 (fr) |
| FI (1) | FI954257A (fr) |
| GR (1) | GR3025405T3 (fr) |
| HU (1) | HUT73432A (fr) |
| IL (1) | IL115235A0 (fr) |
| MY (1) | MY132008A (fr) |
| NO (1) | NO953569L (fr) |
| NZ (1) | NZ272976A (fr) |
| PE (1) | PE50296A1 (fr) |
| PL (1) | PL310372A1 (fr) |
| SI (1) | SI0702015T1 (fr) |
| SK (1) | SK111195A3 (fr) |
| TR (1) | TR199501115A2 (fr) |
| ZA (1) | ZA957699B (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002314744A1 (en) | 2001-04-17 | 2002-10-28 | Sepracor, Inc. | Thiazole and other heterocyclic ligands and use thereof |
| DE10333935A1 (de) * | 2003-07-25 | 2005-02-24 | Aventis Pharma Deutschland Gmbh | Neue bicyclische Cyanoheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| FR2858321B1 (fr) * | 2003-07-28 | 2006-01-20 | Servier Lab | Nouveaux derives d'oximes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1249992A (fr) * | 1983-11-10 | 1989-02-14 | Marcel Muller | Oxazolidines |
| ES2139633T3 (es) * | 1992-08-31 | 2000-02-16 | Sankyo Co | Derivados de oxazolidina con propiedades anti-diabetica y anti-obesidad, su preparacion y su utilizacion terapeutica. |
| US5321036A (en) * | 1993-02-10 | 1994-06-14 | Bristol-Myers Squibb Company | Thiazole and oxazole-based β3 adrenergic receptor agonists |
| EP0645387A1 (fr) * | 1993-04-07 | 1995-03-29 | Taiho Pharmaceutical Co., Ltd. | Derive de thiazolidine et composition pharmaceutique contenant ce derive |
-
1995
- 1995-09-06 SK SK1111-95A patent/SK111195A3/sk unknown
- 1995-09-07 CZ CZ952295A patent/CZ229595A3/cs unknown
- 1995-09-11 AT AT95810561T patent/ATE158585T1/de not_active IP Right Cessation
- 1995-09-11 AU AU30552/95A patent/AU3055295A/en not_active Abandoned
- 1995-09-11 EP EP95810561A patent/EP0702015B1/fr not_active Expired - Lifetime
- 1995-09-11 PE PE1995278667A patent/PE50296A1/es not_active Application Discontinuation
- 1995-09-11 CA CA002157950A patent/CA2157950A1/fr not_active Abandoned
- 1995-09-11 NO NO953569A patent/NO953569L/no unknown
- 1995-09-11 DE DE69500758T patent/DE69500758T2/de not_active Expired - Fee Related
- 1995-09-11 FI FI954257A patent/FI954257A/fi not_active Application Discontinuation
- 1995-09-11 SI SI9530038T patent/SI0702015T1/xx unknown
- 1995-09-11 DK DK95810561.1T patent/DK0702015T3/da active
- 1995-09-11 ES ES95810561T patent/ES2108550T3/es not_active Expired - Lifetime
- 1995-09-11 MY MYPI95002690A patent/MY132008A/en unknown
- 1995-09-11 IL IL11523595A patent/IL115235A0/xx unknown
- 1995-09-11 KR KR1019950029478A patent/KR960010649A/ko not_active Application Discontinuation
- 1995-09-11 NZ NZ272976A patent/NZ272976A/en unknown
- 1995-09-11 PL PL95310372A patent/PL310372A1/xx unknown
- 1995-09-11 JP JP7257240A patent/JPH08109183A/ja active Pending
- 1995-09-12 HU HU9502663A patent/HUT73432A/hu unknown
- 1995-09-12 CO CO95041744A patent/CO4410332A1/es unknown
- 1995-09-12 BR BR9504004A patent/BR9504004A/pt not_active Application Discontinuation
- 1995-09-12 TR TR95/01115A patent/TR199501115A2/xx unknown
- 1995-09-12 CN CN95115726A patent/CN1130186A/zh active Pending
- 1995-09-13 ZA ZA957699A patent/ZA957699B/xx unknown
-
1997
- 1997-11-19 GR GR970403050T patent/GR3025405T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2108550T3 (es) | 1997-12-16 |
| SI0702015T1 (en) | 1998-02-28 |
| FI954257A0 (fi) | 1995-09-11 |
| HUT73432A (en) | 1996-07-29 |
| IL115235A0 (en) | 1995-12-31 |
| DE69500758T2 (de) | 1998-02-26 |
| NO953569L (no) | 1996-03-14 |
| FI954257A (fi) | 1996-03-14 |
| GR3025405T3 (en) | 1998-02-27 |
| DE69500758D1 (de) | 1997-10-30 |
| AU3055295A (en) | 1996-03-28 |
| MY132008A (en) | 2007-09-28 |
| EP0702015A1 (fr) | 1996-03-20 |
| JPH08109183A (ja) | 1996-04-30 |
| EP0702015B1 (fr) | 1997-09-24 |
| HU9502663D0 (en) | 1995-11-28 |
| ATE158585T1 (de) | 1997-10-15 |
| NO953569D0 (no) | 1995-09-11 |
| ZA957699B (en) | 1997-03-13 |
| CO4410332A1 (es) | 1997-01-09 |
| DK0702015T3 (da) | 1998-01-12 |
| CZ229595A3 (en) | 1996-04-17 |
| TR199501115A2 (tr) | 1996-06-21 |
| PE50296A1 (es) | 1996-12-05 |
| PL310372A1 (en) | 1996-03-18 |
| CN1130186A (zh) | 1996-09-04 |
| BR9504004A (pt) | 1996-09-24 |
| NZ272976A (en) | 1996-09-25 |
| CA2157950A1 (fr) | 1996-03-14 |
| KR960010649A (ko) | 1996-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1264384A (zh) | 稠合1,2,4-噻二嗪衍生物及其制备方法和用途 | |
| CA2915325C (fr) | Derives amino-triazine et composition pharmaceutique contenant lesdits derives | |
| JP5766198B2 (ja) | 縮合アミノジヒドロピリミジン誘導体 | |
| EP1446115B1 (fr) | Derives cyanoalkylamino utilises comme inhibiteurs de la protease | |
| KR100915481B1 (ko) | 아미노퀴나졸린 화합물 | |
| EP1302461B1 (fr) | Inhibiteurs de production de tnf-alpha | |
| JP5897566B2 (ja) | 環式ｎ，ｎ’−ジアリールチオ尿素及びｎ，ｎ’−ジアリール尿素−アンドロゲン受容体アンタゴニスト、抗癌剤、その調製のための方法及び使用 | |
| CH620925A5 (fr) | ||
| TW472059B (en) | Thienopyrimidines, preparation process thereof, and pharmaceutical composition containing the same | |
| CN113501821B (zh) | 具有mgat-2抑制活性的稠合环衍生物 | |
| SK283394B6 (sk) | Zlúčeniny 4-fenylpiperidínu a jej farmaceuticky prijateľné soli, spôsob ich prípravy, liečivo s ich obsahom a ich použitie | |
| CN1330655A (zh) | 稠合的1,2,4－噻二嗪衍生物、其制备方法和用途 | |
| NO163857B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidindionforbindelser. | |
| PL173725B1 (pl) | Sól 5-[4-[2-(N-metylo-N-(2-pirydylo)amino)etoksy] benzylo]tiazolidyno-2,4-dionu z kwasem maleinowym oraz sposób wytwarzania soli 5-[4-[2-(N-metylo-N-(2-pirydylo)amino)etoksy] benzylo] tiazolidyno-2,4-dionu z kwasem maleinowym | |
| CZ20032696A3 (cs) | Thiohydantoiny a jejich použití při léčení cukrovky | |
| DE60025848T2 (de) | Pyrimidin-derivate als selective inhibitoren von cox-2 | |
| DE69718498T2 (de) | Substituierte benzoylthiazolderivate und sie enthaltende medikamente | |
| WO2004106295A2 (fr) | Piperodines et pyrrolidines substituees utilisees comme modulateurs du recepteur de detection du calcium et procede correspondant | |
| US20210053951A1 (en) | Salt Forms Of 4-Cyano-N-(4,4-Dimethylcyclohex-1-EN-1-YL)-6-(2,2,6,6-Tetramethyltetrahydro-2H-Pyran-4-YL)Pyridin-3-YL)-1H-Imidazole-2-Carboximide | |
| SK111195A3 (en) | Bicyclic ethers substituted with oxazole and thiazole, process for producing thereof and pharmaceutical composition containing same | |
| CS227012B2 (en) | Method of preparing 2-amino-3-benzoyl-phenylacetamide | |
| JPH02167264A (ja) | カルバジン酸誘導体、その製造法及び製剤 | |
| US5912261A (en) | Carboxyalkyl heterocyclic derivatives | |
| DE69418961T2 (de) | Benzothiazol-derivate, verfahren zur herstellung sowie anwendungen | |
| BR112021012428A2 (pt) | Derivado de dihidropirazolopirazinona tendo atividade inibitória de mgat2 |